qRT-PCR analysis also proved significantly higher expression of IGF2BP1, IGF2BP2, and IGF2BP3 in CRC patients compared to normal subjects (Figures 3C–E). The gene discussed is IGF2BP3; the disease is colorectal carcinoma.